Replies to post #696369 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

So again I'll ask, how is this 8 million any different from the other 40 million already sold this year?

I do not claim to know, but I could guess.

The SEC has various disclosure rules. And they are often open to interpretation. One such is for a specific agreement such as this. It must be disclosed if material. But what is material? Some bright lines are based on the size of the transaction.

I would have to search, but it is very possible NWBO never had a single transaction this large that was not disclosed. Most of their shares dribble out in small amounts that are not material.

The SEC does have a hard number requiring disclosure based on total shares since last disclosure, but I think NWBO is well under that.,

EDIT: Also, most of those 40M were either exchanges for debt or warrant/C/option conversions.

[learningcurve2020]

No, those shares sold in the Q's are from converted options / warrant deals struck ages ago. The company has no control over whether or not those holders sell out and presumably the sellers have no knowledge of material information. For the company to strike this current deal, however, they cannot be in possession of any material information that'd drastically increase the share price.


>>They've been 'showing the cards' (aka disclosing how many shares they've sold and at what valuation) in every 10Q for the past 5 years.